Pharmafile Logo

Ventiv Health Ltd.

In 1995 Ventiv Kft. commenced its operations in the areas of pharmaceutical labor recruitment and labor outsourcing. The company initially conducted its activity under English ownership and the name RDL. Today the company is 100% Hungarian owned. The name Ventiv Group encompasses the operation of four business lines. In the form of a company group, it is the market leading Hungarian pharmaceutical HR service provider.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

Horvat u. 14-24., Budapest, 1027, Hungary
3612140658

 Latest Content from PMHub 

The silent drop-off: How disengagement shows up in everyday behaviour

Press Releases | May 5, 2026 | Mednet

In healthcare, disengagement rarely announces itself. It doesn’t always appear as refusal or a clear decision to stop treatment. More often, it shows up quietly, in what is delayed, avoided...

Keep the Beat Going: Education and Impact at the European Society of Cardiology Heart Failure Congress 2026

Did you know? Over 320,000 learners have engaged with heart failure content on Medscape. With such an enthusiastic audience for our education, we’re thrilled to be joining cardiology professionals from...

The Power of Partnership in Respiratory Care

In the fast-paced world of modern medicine, success is often measured by the volume of tests and the precision of data. However, as Dr. Doreen Addrizzo-Harris and Dr. Martina Flammer...

Why clinical innovation doesn’t translate into real-life outcomes

Press Releases | April 30, 2026 | Mednet

We’ve made extraordinary progress in healthcare. However, outcomes depend on whether people can make treatment work in their lives.

Strategies to enhance the provider and patient EAP experience

Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Beyond the Linear Path: Leading with Your Full Self

Listen to the full episode here. In the latest episode of the Hear From Her podcast, Giulia Ghibellini (Teva Pharmaceuticals) and Professor Amanda Kirby (Do-IT Solutions) share how their experiences...

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.